Saudi Arabia
Tuberculosis profile
Population  2013 29 million
Estimates of TB burden * 2013 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 0.96 (0.096–2.8) 3.3 (0.33–9.7)
Mortality (HIV+TB only) 0 (–) 0 (–)
Prevalence  (includes HIV+TB) 4.6 (1.6–9.2) 16 (5.6–32)
Incidence  (includes HIV+TB) 4 (3.5–4.5) 14 (12–16)
Incidence (HIV+TB only)        
Case detection, all forms (%) 87 (77–99)    
Estimates of MDR-TB burden * 2013   New   Retreatment
% of TB cases with MDR-TB 1.8 (1.4–2.4) 16 (15–17)
MDR-TB cases among notified pulmonary
TB cases
44 (34–59) 37 (36–38)
TB case notifications 2013 New ** Relapse
Pulmonary, bacteriologically confirmed 1 976   97
Pulmonary, clinically diagnosed 473   9
Extrapulmonary 878   2
       
Total new and relapse 3 435    
Previously treated, excluding relapses 127    
Total cases notified 3 562    
Among 3 435 new and relapse cases:
104 (3%) cases aged under 15 years; male:female ratio: 2.0
Reported cases of RR-/MDR-TB 2013 New Retreatment Total **
Cases tested for RR-/MDR-TB 10 (<1%) 13 (6%) 23
Laboratory-confirmed RR-/MDR-TB cases     26
Patients started on MDR-TB treatment     23
TB/HIV 2013 Number (%)
TB patients with known HIV status 1 835 (52)
HIV-positive TB patients 77 (4)
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT)    
HIV-positive TB patients on antiretroviral therapy (ART)    
HIV-positive people screened for TB    
HIV-positive people provided with IPT    
Treatment success rate (%)
New and relapse cases registered in 2012 64
Previously treated cases, excluding relapse, registered in 2012 45
HIV-positive TB cases, all types, registered in 2012 19
RR-/MDR-TB cases started on second-line treatment in 2011  
XDR-TB cases started on second-line treatment in 2011  
Laboratories 2013  
Is second-line drug susceptibility testing available? Yes, outside
country
Financing TB control 2014  
National TB programme budget (US$ millions)  
* Ranges represent uncertainty intervals
** Includes cases with unknown previous TB treatment history
***
(Rate per 100 000 population per year)
Mortality graph
   Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
   Prevalence

(Rate per 100 000 population per year)
Incidence graph
   Notified (new and relapse)   Incidence
   Incidence (HIV+TB only)

(Number of patients)
CPT ART graph
   HIV-positive TB patients
   on CPT   on ART

Treatment success rate (%)
tx success graph
   New   Retreatment
   New and relapse   Retreatment, excluding
relapse
   HIV-positive   RR-/MDR-TB   XDR-TB

 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 Generated: 2015-07-07 Data: www.who.int/tb/data